Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria

Archives of Internal Medicine

Volumn 161, Issue 16, 2001, Pages 2000-2005

  Monster, Taco B M ^a   Janssen, Wilbert M T ^a   De Jong, Paul E ^a   De Jong Van Den Berg, Lolkje T W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DESOGESTREL; DIENESTROL; ESTRIOL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GESTODENE; LEVONORGESTREL; LYNESTRENOL; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; OBESITY; ORAL CONTRACEPTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; ALBUMIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG USE; HIGH RISK PATIENT; HORMONE SUBSTITUTION; KIDNEY DISEASE; LONG TERM CARE; NETHERLANDS; QUESTIONNAIRE;

EID: 0035955925     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.16.2000     Document Type: Article

References (25)

1. Epidemiology of oral contraceptives and cardiovascular disease
2. Hormonal contraception and risk of cardiovascular disease: An international perspective
3. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
4. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study
5. Myocardial infarction in users of low-dose oral contraceptives
6. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: Results from the transnational study on oral contraceptives and the health of young women
7. Oral contraceptives and myocardial infarction: Results of the MICA case-control study
8. Postmenopausal hormone therapy and mortality
9. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
10. Hormone replacement therapy for secondary prevention of coronary heart disease
11. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
12. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
13. Study throws doubt on protective effects of HRT for heart disease
14. Ups and downs for HRT and heart disease
15. Albuminuria reflects widespread vascular damage: The Steno hypothesis
16. Microalbuminuria predicts mortality in non-insulin-dependent diabetics
17. Microalbuminuria as predictor of increased mortality in elderly people
18. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington diabetes survey
19. Microalbuminuria and its relation to cardiovascular disease and risk factors: A population-based study of 1254 hypertensive individuals
20. Urinary albumin excretion is associated with renal functional abnormalities in a non-diabetic population
21. Validation of pharmacy records in drug exposure assessment
22. Renal characteristics and effect of angiotensin suppression in oral contraceptive users
23. Impaired procoagulant-anticoagulant balance during hormone replacement therapy? a randomised placebo-controlled 12-week study
24. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
25. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women